EMA Authorised: Levetiracetam Sun (levetiracetam) — Sun Pharmaceutical Industries Europe B.V.

View source ↗

Summary

The EMA has authorised Levetiracetam Sun, a generic levetiracetam product by Sun Pharmaceutical Industries Europe B.V., for epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Levetiracetam Sun (levetiracetam)

Snippet

Status: Authorised. Therapeutic area: Epilepsy. MAH: Sun Pharmaceutical Industries Europe B.V.. Decision date: 22/12/2025